3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Ovarian Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arellano, RO; Castañeda-García, C; Garay, E; García-Carrancá, A; Martínez-Ramírez, AS; Pérez-Montiel, D; Robles-Martínez, L; Vázquez-Cuevas, FG | 1 |
| Arellano, RO; Cruz-Rico, A; Garay, E; García-Carrancá, A; Juárez, B; Pérez-Montiel, D; Vázquez-Cuevas, FG | 1 |
2 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Ovarian Neoplasms
| Article | Year |
|---|---|
Paracrine stimulation of P2X7 receptor by ATP activates a proliferative pathway in ovarian carcinoma cells.
Topics: Adenosine Triphosphate; Adult; Aged; Apyrase; Calcium; Cell Line, Tumor; Cell Proliferation; Female; Humans; MAP Kinase Signaling System; Middle Aged; Ovarian Neoplasms; Paracrine Communication; Receptors, Purinergic P2X7 | 2014 |
Differential expression of the P2X7 receptor in ovarian surface epithelium during the oestrous cycle in the mouse.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Calcium; Cell Line, Tumor; Cells, Cultured; Epithelium; Estrous Cycle; Female; Humans; In Situ Nick-End Labeling; Mice; Ovarian Neoplasms; Ovary; Purinergic P2X Receptor Agonists; Purinergic P2X Receptor Antagonists; Pyridines; Receptors, Purinergic P2X7; Tetrazoles | 2013 |